標(biāo)題: Titlebook: Exploring Drug Delivery to the Peritoneum; Ranjita Shegokar Book 2023 Springer Nature Switzerland AG 2023 peritoneal cavity.GI tract and R [打印本頁] 作者: autoantibodies 時間: 2025-3-21 17:38
書目名稱Exploring Drug Delivery to the Peritoneum影響因子(影響力)
書目名稱Exploring Drug Delivery to the Peritoneum影響因子(影響力)學(xué)科排名
書目名稱Exploring Drug Delivery to the Peritoneum網(wǎng)絡(luò)公開度
書目名稱Exploring Drug Delivery to the Peritoneum網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Exploring Drug Delivery to the Peritoneum被引頻次
書目名稱Exploring Drug Delivery to the Peritoneum被引頻次學(xué)科排名
書目名稱Exploring Drug Delivery to the Peritoneum年度引用
書目名稱Exploring Drug Delivery to the Peritoneum年度引用學(xué)科排名
書目名稱Exploring Drug Delivery to the Peritoneum讀者反饋
書目名稱Exploring Drug Delivery to the Peritoneum讀者反饋學(xué)科排名
作者: Organization 時間: 2025-3-21 23:25
High Time Resolution Astrophysicst the widespread acceptance of this promising modality, PIPAC. Improved training opportunities, research methodologies, and increasing clinician interest ensure that PIPAC is gaining popularity in the country and promises to improve patient survival and quality of life.作者: Pillory 時間: 2025-3-22 01:41 作者: 甜食 時間: 2025-3-22 07:25
Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC): Promising Strides from India,t the widespread acceptance of this promising modality, PIPAC. Improved training opportunities, research methodologies, and increasing clinician interest ensure that PIPAC is gaining popularity in the country and promises to improve patient survival and quality of life.作者: SEEK 時間: 2025-3-22 12:35
Book 2023rget several other diseases where lymphatic drug delivery is desired without dumping large?amounts?of?the?drug. Till recently, it was thought that treatment with curative intent was impossible but that was challenged by the introduction of cytoreductive surgery (CRS) and heated intraperitoneal chemo作者: 圖表證明 時間: 2025-3-22 13:03 作者: 圖表證明 時間: 2025-3-22 19:31
HIPEC: Concept and Fundamentals in Colorectal Cancer Peritoneal Metastasis Treatment,ct. Success and failure of HIPEC compared to clinical trials, demonstrating the limitations of the technique, are also mentioned..Finally, we got our opinion on HIPEC in colorectal cases fleshed out writing by an independent expert. We introduce with permission the concepts and the future of HIPEC with the emergence of new technology.作者: 煩擾 時間: 2025-3-22 23:36
ne stop information source for all stages of drug targeting .The Peritoneal cavity (PC) is?the?key metastatic site for intra-abdominal malignancies (e.g.,?GI tract and rectal cancer). PC?sites?can be used to target several other diseases where lymphatic drug delivery is desired without dumping large作者: Debrief 時間: 2025-3-23 03:28 作者: 死亡率 時間: 2025-3-23 06:23 作者: sclera 時間: 2025-3-23 12:50 作者: 壓迫 時間: 2025-3-23 14:46 作者: 瑣碎 時間: 2025-3-23 19:28
Die Bef?higung zum ?High Value Management“s to apply HIPEC procedure are well defined in this chapter. Special description has been done including general indications and the entire procedure step by step, with exhaustive details. Drugs used, dosage ranges in liquid and nanoparticles presentation used in HIPEC are described in a clear subje作者: 手段 時間: 2025-3-23 22:26 作者: AUGER 時間: 2025-3-24 06:11
https://doi.org/10.1057/9780230378063ertheless, drug penetration into the tumor with IP injection in many cases is insufficient. Therefore, it is essential to improve our understanding of the mechanisms and parameters affecting drug penetration to optimize treatment, introduce new treatment methods, and minimize drug toxicity. Computat作者: ARM 時間: 2025-3-24 07:00 作者: 激怒 時間: 2025-3-24 10:49
https://doi.org/10.1007/978-3-030-58365-1livery systems have prolonged the survival rate by limiting the peritoneal disease and systemic toxicity. However, to our knowledge, so far, there is no drug available in clinical practice that has been formulated specifically for IP administration. Due to significant variations in the procedures of作者: 多骨 時間: 2025-3-24 18:36 作者: Substance-Abuse 時間: 2025-3-24 22:21 作者: 受辱 時間: 2025-3-25 01:44
https://doi.org/10.1007/978-3-031-31694-4peritoneal cavity; GI tract and Rectal cancer; Lymphatic Drug delivery; heated intraperitoneal chemothe作者: 男生如果明白 時間: 2025-3-25 06:05
978-3-031-31696-8Springer Nature Switzerland AG 2023作者: 1FAWN 時間: 2025-3-25 08:28 作者: 調(diào)整校對 時間: 2025-3-25 12:53 作者: Aspiration 時間: 2025-3-25 17:41 作者: heterogeneous 時間: 2025-3-25 20:47
Liposomes and Lipid Nanoparticles as Peritoneal Drug Delivery Systems, short retention times, and poor bioavailability. The objectives of this chapter are to briefly review the features, classification, and applications of drug lipid nanoparticles..Liposomes and lipid nanoparticles can be used to deliver drugs to the peritoneum, allowing the targeted treatment of dise作者: Arthritis 時間: 2025-3-26 01:40 作者: forager 時間: 2025-3-26 04:57 作者: 失敗主義者 時間: 2025-3-26 11:05
Drug Delivery Systems to the Peritoneum: Current Status and Future Perspectives,s. Future studies in the chapter mainly focus on improving the clinical relevance of the experiments, standardizing the experimental study setup, and improving their methodological quality and reporting.作者: Dorsal 時間: 2025-3-26 15:11
Exploring the Intraperitoneal Route in a New Way for Preclinical Testing,his book chapter emphasizes on various aspects of IP drug delivery including biology of peritoneal cavity, factors affecting pharmacokinetics of drugs, systems used in IP drug delivery and animal models. This will open the new doors for successful treatment of IP disease conditions, provide clear su作者: 要塞 時間: 2025-3-26 18:45 作者: seruting 時間: 2025-3-27 00:32 作者: adipose-tissue 時間: 2025-3-27 03:39 作者: 誹謗 時間: 2025-3-27 05:44
High Velocity Microparticles in Spacemer which is however been not observed especially when delivered with albumin-based biodegradable substances. These dosage forms have unique perspective in delivering drug molecules, genes, and peptide molecules as therapeutic moieties. Formulation strategies have focused on the safe portal of medic作者: 盡忠 時間: 2025-3-27 09:32 作者: Nonflammable 時間: 2025-3-27 14:51 作者: 不發(fā)音 時間: 2025-3-27 20:14
https://doi.org/10.1007/978-3-030-58365-1his book chapter emphasizes on various aspects of IP drug delivery including biology of peritoneal cavity, factors affecting pharmacokinetics of drugs, systems used in IP drug delivery and animal models. This will open the new doors for successful treatment of IP disease conditions, provide clear su作者: 撕裂皮肉 時間: 2025-3-28 01:42 作者: sebaceous-gland 時間: 2025-3-28 04:54
Intraperitoneal Delivery Systems,scites to cancer. Given the nature of IPD, this modality of drug delivery has received a lot of interest and attention specifically in the area of treating tumors in the colon, ovary, and abdominal region. This chapter attempts to provide an overview of key principles of IPD with respect to concentr作者: 沒有貧窮 時間: 2025-3-28 10:09
Liposomes and Lipid Nanoparticles as Peritoneal Drug Delivery Systems,ave shown potential as a means of delivering drugs to target sites in the body including the peritoneum. The peritoneum is a thin membrane that lines the abdominal cavity and covers abdominal organs. They play an important role in the transport of fluids, nutrients, and waste products. Diseases such作者: 樹木中 時間: 2025-3-28 11:44
Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC): Promising Strides from India,y. An attempt has been made to understand how PIPAC as a modality can be made to flourish in the fertile environment of a country like India. The burden of various malignancies, the evolution of PSO, the building evidence and contribution to the literature regarding PIPAC, the healthcare structure a作者: Cougar 時間: 2025-3-28 14:53 作者: 過去分詞 時間: 2025-3-28 18:56
Peritoneal Implants and Drug Delivery,e form retention, and an ideal site for delivering depot of therapeutic substance to the visceral organs. Pathologies of tumor or infectious origin are more to be treated through the peritoneal route since oral administration requires heavy dose to achieve local drug concentration. Hydrogels, nanoca作者: 極深 時間: 2025-3-28 23:10 作者: Ventricle 時間: 2025-3-29 06:06
Drug Delivery Systems to the Peritoneum: Current Status and Future Perspectives, of the desired drug molecule in the peritoneum cavity. Current studies and research suggest IP delivery is a promising technique for drug delivery against peritoneal drug delivery as compared to conventional systemic administration. However, the peritoneal drug delivery system faces many challenges作者: dissent 時間: 2025-3-29 10:33
